The David H. Koch Institute for Integrative Cancer Research at MITThe David H. Koch Institute for Integrative Cancer Research at MIT

Massachusetts Institute of Technology

National Cancer Institute Cancer Center

Science + Engineering... Conquering Cancer Together

The Judith Ann Lippard Memorial Lectureship in Cancer Research

The Inaugural Judith Ann Lippard Memorial Lecture in Cancer Research:
PI 3 Kinase & Cancer Metabolism 

Friday, October 23, 2015
Koch Institute Auditorium (76-156)

Lewis C. Cantley, PhD
The Margaret and Herman Sokol Professor
Director of the Sandra and Edward Meyer Cancer Center
Weill Cornell Medical College/NewYork-Presbyterian Hospital

About Dr. Cantley

Lewis CantleyLewis C. Cantley, PhD, is the Margaret and Herman Sokol Professor and Director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medical College/New York Presbyterian Hospital. Dr. Cantley grew up in West Virginia and graduated from West Virginia Wesleyan College in 1971. He obtained a Ph.D. in biophysical chemistry from Cornell University in 1975 and did postdoctoral training at Harvard University. Prior to taking the position at Weill Cornell, he taught and did research in biochemistry, physiology, and cancer biology in Boston, most recently at Beth Israel Deaconess Medical Center and Harvard Medical School. His laboratory discovered the PI 3-Kinase pathway that plays a critical role in insulin signaling and in cancers.

Dr. Cantley was elected to the American Academy of Arts and Sciences in 1999 and to the National Academy of Sciences in 2001. Among his other awards are the ASBMB Avanti Award for Lipid Research in 1998, the Heinrich Weiland Preis for Lipid Research in 2000, the Caledonian Prize from the Royal Society of Edinburgh in 2002, the 2005 Pezcoller Foundation–AACR International Award for Cancer Research, the 2009 Rolf Luft Award for Diabetes and Endocrinology Research from the Karolinska Institute, Stockholm, the 2011 Pasrow Prize for Cancer Research, the 2013 Breakthrough in Life Sciences Prize, and the 2013 Jacobaeus Prize for Diabetes Research from the Karolinska Institute.

Dr. Cantley was elected into the Institute of Medicine in 2014 and most recently is the recipient of the 2015 AACR Princess Takamatsu Memorial Lectureship, the 2015 Ross Prize in Molecular Medicine, and the 2015 Canada Gairdner International Award.

About the Lecture

Judith LippardThe Judith Ann Lippard Memorial Lecture was established in 2014 in memory of Judy Lippard, the wife of Stephen J. Lippard, the Arthur Amos Noyes Professor of Chemistry at MIT. Judy died of endometrial cancer on September 9, 2013. Steve, Josh, and Alex Lippard, together with countless friends, students, and colleagues created the lectureship to honor Judy’s memory and celebrate her remarkable love of life.

The creation of the Judith Ann Lippard Lectureship was inspired by a similar lecture, created in 1974 in memory of Judy’s and Steve’s eldest son, Andrew, who died from a neurological disorder at age 7. Over time, the Andrew Mark Lippard Lecture at Columbia University has become one of the preeminent neurology lectures in the world.

The Judith Ann Lippard Lectureship will bring together the most innovative minds in cancer research from a variety of disciplines—biology, chemistry, engineering, clinical medicine—and feature individuals whose research has the possibility to change the face of cancer. The Lippard Lecture will also unite two extraordinary cancer centers—MIT’s Koch Institute and the Massachusetts General Hospital Cancer Center. In addition to the formal lecture at MIT, the honorand will not only deliver Grand Rounds at MGH, but will also spend time with trainees, researchers, and physician-scientists at both institutions, thus inspiring the best and brightest young minds to advance cancer therapies.

Selection Committee

Tyler Jacks, PhD
Stephen J. Lippard, PhD, ex officio
Jonathan Rosand, MD, MSc
Phillip A. Sharp, PhD 

Supporting the Lippard Lectures

To join the Lippard family in celebrating Judy's life and legacy, please contact Lisa Schwarz, Managing Director of Development, Koch Institute for Integrative Cancer Research at MIT: 617-324-7399;, or give online.

Logo block